Taken together, we propose that the deletion of PTPRM may contribute to the triplets’ autoimmune manifestations by reducing the negative regulation of STAT3 phosphorylation, thereby increasing Th17 cell fractions and promoting autoimmunity. Here, PTPRM is linked to Autoimmunity.